Literature DB >> 12484542

Chromatographic determination of clotrimazole, ketoconazole and fluconazole in pharmaceutical formulations.

E M Abdel-Moety1, F I Khattab, K M Kelani, A M AbouAl-Alamein.   

Abstract

High-performance liquid chromatographic technique has been developed for the determination or some azolcsantifungals namely, clotrimazole (CZ), ketoconazole (KZ) and fluconazole (FZ), in pure forms and in pharmaceutical formulations. The proposed HPLC-method can be successfully applied as a stability indicating method for the determination of CZ in presence of its acid degradation products; viz (2-chlorophenyl)-diphenyl methanol and imidazole. The analyzed drugs were separated on a reversed-phase column [Bondapak C18 (10 microm, 25 cm x 4.6 mm, i.d.)] using a mobile phase containing acetonitrilc+25 mM trishydroxymeihyl aminomethane in phosphate butter (pH 7) = 55:45 (v/v), with UV-detection at 260 nm. The differences in the retention times (tR) of the three azoles permit their use as internal standard for each other. In addition, a coupled TLC-densitometric method has been also applied as a stability indicating method to separate and quantify CZ alone or in presence of byproducts impurities and/or its acid degradation products. The TLC-fractionation was performed on a precoated silica gel F254 plates using a solvent system consisting of chloroform+acetone+ammonia (25%) (7:1:0.1, by volumes), CZ was well separated from its acid degradation products and quantified by densitometric scanning at 260 nm.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12484542     DOI: 10.1016/s0014-827x(02)01270-3

Source DB:  PubMed          Journal:  Farmaco        ISSN: 0014-827X


  6 in total

1.  Clotrimazole-cyclodextrin based approach for the management and treatment of Candidiasis - A formulation and chemistry-based evaluation.

Authors:  Noorullah Naqvi Mohammed; Pankaj Pandey; Nayaab S Khan; Khaled M Elokely; Haining Liu; Robert J Doerksen; Michael A Repka
Journal:  Pharm Dev Technol       Date:  2015-04-29       Impact factor: 3.133

2.  Development and Validation of HPTLC Method for the Estimation of Clotrimazole in Bulk drug and Tablet Formulation.

Authors:  Parul Parmar; Ankita Mehta
Journal:  Indian J Pharm Sci       Date:  2009-07       Impact factor: 0.975

3.  Clotrimazole as a Cancer Drug: A Short Review.

Authors:  S Kadavakollu; C Stailey; C S Kunapareddy; S White
Journal:  Med Chem (Los Angeles)       Date:  2014

4.  Identification of major degradation products of ketoconazole.

Authors:  Rajendra A Mhaske; Shirish Sahasrabudhe
Journal:  Sci Pharm       Date:  2011-10-13

Review 5.  VDAC1 as Pharmacological Target in Cancer and Neurodegeneration: Focus on Its Role in Apoptosis.

Authors:  Andrea Magrì; Simona Reina; Vito De Pinto
Journal:  Front Chem       Date:  2018-04-06       Impact factor: 5.221

6.  Improvement of solubility and dissolution properties of clotrimazole by solid dispersions and inclusion complexes.

Authors:  Gehan Balata; M Mahdi; Rania Abu Bakera
Journal:  Indian J Pharm Sci       Date:  2011-09       Impact factor: 0.975

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.